p63 coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract

被引:87
作者
Ince, TA
Cviko, AP
Quade, BJ
Yang, A
McKeon, FD
Mutter, GL
Crum, CP
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA
关键词
D O I
10.1016/S0002-9440(10)64387-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
p63 is a p53 homologue required for cutaneous development that is expressed in immature squamous epithelium and reserve cells of the cervix. Humans with p63 mutations exhibit defects in limb, accessory organ (skin appendage, breast, prostate), and genitourinary development. Because p63 expression patterns imply a strong role of the gene in the female genital tract development, newborn female p63 -/-, +/-, and +/+ mice were examined in situ, dissected, and compared. Nuclear p63 protein was localized to the skin, vagina, bladder, urethra, and basal columnar cells of the caudal uterus in p63 +/+ and +/- animals. P63-/- mice exhibited abnormal genital morphogenesis with hypoplastic genitalia, a single cloacal opening, and persistence of columnar epithelium at lower genital tract sites that normally undergo squamous and urothelial differentiation. The defects observed support p63-dependent pathways of genital tract development that permit externally, ectodermal basal cell replenishment integral to reciprocal epithelial stromal. signaling, urorectal septation, and modeling of the external genitalia, and internally, the emergence of basal epithelial cell populations capable of divergent epithelial cell differentiation in the vagina, cervix, and urinary tract. Defects in the first pathway explain imperforate anus, vaginal septum, genital hypoplasia, and micropenis reported in humans with p63 mutations. The second is necessary for the generation of multipotential reserve cells in the cervix and may be operative in other epithelial stromal interactions integral to the emergence of uterine basal cells later in life.
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 39 条
[1]   CLOACAL ANOMALIES AND OTHER URORECTAL SEPTAL-DEFECTS IN FEMALE-PATIENTS - A SPECTRUM OF ANATOMICAL ABNORMALITIES [J].
ALLEN, TD ;
HUSMANN, DA .
JOURNAL OF UROLOGY, 1991, 145 (05) :1034-1039
[2]   p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast [J].
Barbareschi, M ;
Pecciarini, L ;
Cangi, MG ;
Macrì, E ;
Rizzo, A ;
Viale, G ;
Doglioni, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (08) :1054-1060
[3]   Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome [J].
Celli, J ;
Duijf, P ;
Hamel, BCJ ;
Bamshad, M ;
Kramer, B ;
Smits, APT ;
Newbury-Ecob, R ;
Hennekam, RCM ;
Van Buggenhout, G ;
van Haeringen, B ;
Woods, CG ;
van Essen, AJ ;
de Waal, R ;
Vriend, G ;
Haber, DA ;
Yang, A ;
McKeon, F ;
Brunner, HG ;
van Bokhoven, H .
CELL, 1999, 99 (02) :143-153
[4]   RESTORATION OF NORMAL MORPHOLOGY AND ESTROGEN RESPONSIVENESS IN CULTURED VAGINAL AND UTERINE EPITHELIA TRANSPLANTED WITH STROMA [J].
COOKE, PS ;
UCHIMA, FDA ;
FUJII, DK ;
BERN, HA ;
CUNHA, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2109-2113
[5]   p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes [J].
Dohn, M ;
Zhang, SZ ;
Chen, XB .
ONCOGENE, 2001, 20 (25) :3193-3205
[6]   Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63 [J].
Duijf, PHG ;
Vanmolkot, KRJ ;
Propping, P ;
Friedl, W ;
Krieger, E ;
McKeon, F ;
Dötsch, V ;
Brunner, HG ;
van Bokhoven, H .
HUMAN MOLECULAR GENETICS, 2002, 11 (07) :799-804
[7]  
Elson DA, 2000, CANCER RES, V60, P1267
[8]   EPIDERMIDALIZATION OF CERVIX [J].
GESCHICKTER, CF ;
FERNANDEZ, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1962, 97 (03) :638-+
[9]  
Innis JW, 1998, CLIN GENET, V53, P337
[10]   p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor [J].
Jung, MS ;
Yun, J ;
Chae, HD ;
Kim, JM ;
Kim, SC ;
Choi, TS ;
Shin, DY .
ONCOGENE, 2001, 20 (41) :5818-5825